Search News
| 23.00 Delayed Data As of 4:00pm ET |  -0.80 / -3.36%Today’s Change | 11.93 Today|||52-Week Range 25.63 | +73.58% Year-to-Date |
| Previous close | 23.80 |
| Today’s open | 23.55 |
| Day’s range | 22.95 - 23.75 |
| Volume | 975,975 |
| Average volume (3 months) | 1,061,870 |
| Market cap | $787.8M |
| Earnings growth (last year) | -8,057.14% |
| Earnings growth (this year) | -49.81% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +14.63% |
| P/E ratio | NM |
| Price/Sales | 0.76 |
| Price/Book | 0.99 |
| Today’s change | Today’s % change | |
|---|---|---|
| BOLDAudentes Therapeutic... | +0.77 | +2.01% |
| ---- | ||
| ADAPAdaptimmune Therapeu... | -0.13 | -1.04% |
| MCRBSeres Therapeutics I... | +0.24 | +2.82% |
| Next reporting date | August 2, 2018 |
| EPS forecast (this quarter) | $0.93 |
| Annual revenue (last year) | $609.9M |
| Annual profit (last year) | -$199.2M |
| Net profit margin | -32.66% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director William K. Heiden |
CFO, Treasurer, Principal Accounting Officer & SVP Edward H. Myles |
Corporate headquarters Waltham, Massachusetts |
